The Next Phase of Human Gene-Therapy Oversight
Publication: New England Journal of Medicine
Published: January 24, 2019
PRIM&R responded to an article in the New England Journal of Medicine, stressing the importance of the Recombinant DNA Advisory Committee (RAC) in fostering public discussion about whether new technologies should be specially regulated, or even initiated.